ScholarIQanswers from OpenAlex & ORCID
Andrew J. Aguirre
ResearcherPublications, citations & collaboration network
Andrew J. Aguirre is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Andrew J. Aguirre have?
ScholarIQindexed works
Andrew J. Aguirre has 803 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Andrew J. Aguirre have?
ScholarIQcitation count
Andrew J. Aguirre has 22,175 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Andrew J. Aguirre?
ScholarIQh-index
Andrew J. Aguirre has an h-index of 60 in OpenAlex.
What is the i10-index of Andrew J. Aguirre?
ScholarIQi10-index
Andrew J. Aguirre has an i10-index of 111 in OpenAlex.
What is the ORCID of Andrew J. Aguirre?
ScholarIQorcid
The ORCID for Andrew J. Aguirre is on the source record.
What is the OpenAlex record for Andrew J. Aguirre?
ScholarIQopenalex
The OpenAlex for Andrew J. Aguirre is on the source record.
What are the most-cited papers on Andrew J. Aguirre?
ScholarIQmost cited works
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
Vasanthi S. Viswanathan, Matthew J. Ryan, Harshil Dhruv, Shubhroz Gill, Ossia M. Eichhoff, Brinton Seashore‐Ludlow, Samuel D. Kaffenberger, John K. Eaton, Kenichi Shimada, Andrew J. Aguirre, Srinivas R. Viswanathan, Shrikanta Chattopadhyay, Pablo Tamayo, Wan Seok Yang, Matthew G. Rees, Sixun Chen, Žarko Bošković, Sarah Javaid, Cherrie Huang, Xiaoyun Wu, Yuen‐Yi Tseng, Elisabeth Roider, Dong Gao, James M. Cleary, Brian M. Wolpin, Jill P. Mesirov, Daniel A. Haber, Jeffrey A. Engelman, Jesse S. Boehm, Joanne Kotz, Cindy Hon, Yu Chen, William C. Hahn, Mitchell P. Levesque, John G. Doench, Michael E. Berens, Alykhan F. Shamji, Paul A. Clemons, Brent R. Stockwell, Stuart L. Schreiber
Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer
Srivatsan Raghavan, Peter Winter, Andrew W. Navia, Hannah L. Williams, Alan DenAdel, Kristen E. Lowder, Jennyfer Galvez-Reyes, Radha L. Kalekar, Nolawit Mulugeta, Kevin S. Kapner, Manisha Raghavan, Ashir A. Borah, Nuo Liu, Sara A. Väyrynen, Andressa Dias Costa, Raymond W.S. Ng, Junning Wang, Emma K. Hill, Dorisanne Ragon, Lauren K. Brais, Alex M. Jaeger, Liam F. Spurr, Yvonne Y. Li, Andrew D. Cherniack, Matthew A. Booker, Elizabeth F. Cohen, Michael Tolstorukov, Isaac Wakiro, Asaf Rotem, Bruce E. Johnson, James M. McFarland, Ewa Sicińska, Tyler Jacks, Ryan J. Sullivan, Geoffrey I. Shapiro, Thomas E. Clancy, Kimberly Perez, Douglas A. Rubinson, Kimmie Ng, James M. Cleary, Lorin Crawford, Scott R. Manalis, Jonathan A. Nowak, Brian M. Wolpin, William C. Hahn, Andrew J. Aguirre, Alex K. Shalek
Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy
Matthew Holderfield, Bianca J. Lee, Jingjing Jiang, Aidan C.A. Tomlinson, Kyle J. Seamon, Alessia Mira, Enrico Patrucco, Grace Goodhart, Julien Dilly, Yevgeniy Gindin, Nuntana Dinglasan, Yingyun Wang, Lo Lai, Shurui Cai, Lingyan Jiang, Nicole Nasholm, Nataliya Tovbis Shifrin, Cristina Blaj, Harshit Shah, James Evans, Nilufar Montazer, Oliver Lai, Jade Shi, Ethan Ahler, Elsa Quintana, Stephanie Chang, Anthony Salvador, Abby Marquez, Jim Cregg, Yang Liu, Anthony N. Milin, Anqi Chen, Tamar Bar Ziv, Dylan Parsons, John E. Knox, Jennifer E. Klomp, Jennifer A. Roth, Matthew G. Rees, Melissa M. Ronan, Antonio Cuevas-Navarro, Feng Hu, Piro Lito, David Santamarı́a, Andrew J. Aguirre, Andrew M. Waters, Channing J. Der, Chiara Ambrogio, Zhengping Wang, Adrian L. Gill, Elena S. Koltun, Jacqueline A.M. Smith, David Wildes, Mallika Singh